Integrin inhibitor, Fradafiban, Purity ≥98%

Cat. No.: X24-08-YM306

Integrin inhibitor, Fradafiban, Purity ≥98%

Synonym: 148396-36-5; BIBU-52; BIBU52; BIBU 52; 2-[(3S,5S)-5-[[4-(4-Carbamimidoylphenyl)phenoxy]methyl]-2-oxopyrrolidin-3-yl]acetic acid

  • CAS Number: 148396-36-5
  • Compound CID: 66000
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Fradafiban is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.
Molecular Weight
367.4
Molecular Formula
C20H21N3O4
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Fradafiban is a cytoskeletal signaling inhibitor that displays the significant potential to act as an effective anti-platelet agent to prevent thrombosis and cardiovascular events by inhibiting platelet aggregation.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.